| Unique ID issued by UMIN | UMIN000061735 |
|---|---|
| Receipt number | R000070650 |
| Scientific Title | A safety study of test food intake in healthy adults: Open-label study |
| Date of disclosure of the study information | 2026/06/10 |
| Last modified on | 2026/05/29 12:08:54 |
A safety study of test food intake in healthy adults
A safety study of test food intake in healthy adults
A safety study of test food intake in healthy adults: Open-label study
A safety study of test food intake in healthy adults: Open-label study
| Japan |
Healthy adults
| Adult |
Others
NO
To evaluate the safety of the test food intake
Safety
Medical interview
Physical examination
Laboratory test values
Adverse event
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
| Food |
Ingestion of test food for 4 weeks
| 20 | years-old | <= |
| 64 | years-old | >= |
Male and Female
(1) Subjects of men and women aged 20 to 64
(2) Subjects with a BMI of 25 or more and less than 30
(3) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
(1) Subjects with a history of serious diseases such as mental disorders, diabetes, liver diseases, renal diseases, gastrointestinal diseases, cardiac diseases, respiratory diseases, peripheral vascular diseases, or other serious diseases.
(2) Subjects who have undergone gastrointestinal surgery.
(3) Subjects with abnormal liver and renal function test values.
(4) Subjects with diseases currently being treated.
(5) Subjects who are allergic to food or drugs.
(6) Subjects with symptoms of anemia.
(7) Female subjects who wish to become pregnant during the study, or who are pregnant (including those who may be pregnant) or lactating.
(8) Subjects who play intense sports or who are on a diet.
(9) Subjects with extremely irregular eating habits.
(10) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) or quasi-drugs during the study period.
(11) Subjects who are continuously treated with pharmaceuticals (including OTC and prescription drugs).
(12) Subjects who drink more than 60 g of pure alcohol per day.
(13) Subjects who smoke more than 21 cigarettes per day on average.
(14) Subjects who are participating in or will participate in other clinical trials at the start of this study.
(15) Subjects who are judged by the investigator or subinvestigator to be inappropriate for the study.
15
| 1st name | Naoki |
| Middle name | |
| Last name | Miura |
Miura Clinic, Medical Corporation Kanonkai
Internal medicine
5300044
Higashitenma building 4F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-6809-5220
info@miura-cl.jp
| 1st name | Makoto |
| Middle name | |
| Last name | Terashima |
Oneness Support Co., Ltd.
Clinical Trial Division
5300044
Higashitenma building 6F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-4801-8917
mterashima@oneness-sup.co.jp
Miura Clinic, Medical Corporation Kanonkai
Kewpie Corporation
Profit organization
The Ethics Committee of Miura Clinic, Medical Corporation Kanonkai
Higashitenma building 4F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-6809-5220
mterashima@miura-cl.jp
NO
医療法人花音会みうらクリニック(大阪府)
| 2026 | Year | 06 | Month | 10 | Day |
Unpublished
Preinitiation
| 2026 | Year | 05 | Month | 27 | Day |
| 2026 | Year | 05 | Month | 28 | Day |
| 2026 | Year | 06 | Month | 11 | Day |
| 2026 | Year | 08 | Month | 31 | Day |
| 2026 | Year | 05 | Month | 29 | Day |
| 2026 | Year | 05 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070650